Ludvigsen, M., Kamper, P., Bendix, K.
, Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B.
, Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011).
Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.
Kamper, P., Bendix, K.
, Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011).
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Haematologica,
96(2), 269-76.
https://doi.org/10.3324/haematol.2010.031542
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2010).
favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21).
Kelsen, J., Schwindt, H.
, Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A.
, Dahlerup, J. F. & Hvas, C. L. (2010).
Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood,
116(21), 4131.
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology. Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
D'Amore, F. A., Madsen, J., Nielsen, R., Engebjerg, M., Sørensen, H. & Bukh, A. (2010).
Use of statins and prognosis in patients with CD-20-positive "De novo" diffuse large b cell lymphoma (DLBCL) treated with rituximab containing regimens.
Haematologica, 282.
Jepsen, J. R.
, d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514
D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009).
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network.
Blood,
114(22), 22.
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia and Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Ludvigsen, M., Ostergaard, M., Vorum, H., Jacobsen, C.
& Honoré, B. (2009).
Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.
B M C Biochemistry,
10(1), 34.
https://doi.org/10.1186/1471-2091-10-34
Zinzani, P. L.
, d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008).
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer,
44(3), 366-73.
https://doi.org/10.1016/j.ejca.2007.12.008
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A. M. D., Karkkainen, M. J., Tainola, T.
, Pedersen, F. S., Sørensen, A. B., Kühle, A. V. D. A. & d'Amore, F. A. (2008).
Correlation between epstein-barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications. In
ANNALS OF ONCOLOGY (Vol. 19, pp. 113-113)
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A.
, d'Amore, F., Gonzalez Diaz, M., Petrini, M., Sebban, C., Zinzani, P. L., van Oers, M. H. J., van Putten, W., Bischof-Delaloye, A., Rohatiner, A., Salles, G., Kuhlmann, J. & Hagenbeek, A. (2008).
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of Clinical Oncology,
26(32), 5156-64.
https://doi.org/10.1200/JCO.2008.17.2015
Dybkær, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L.
, Schmitz, A., d'Amore, F. A. & Chan, W. C. (2007).
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: Gene expression signatures indicative of novel molecular signaling pathways. BMC Gemomics.
BMC Gemomics,
8(230).
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Kamper, P., Kjeldsen, E., Clausen, N., Bendix, K.
, Hamilton-Dutoit, S. & d'Amore, F. (2005).
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
British Journal of Haematology,
129(5), 615-7.
https://doi.org/10.1111/j.1365-2141.2005.05499.x
de Chadarevian, JP., Wolk, JH., Inniss, S., Lischner, HW.
, d'Amore, F. A., Faerber, EN. & Isaacson, GC. (1997).
A newly recognized cause of wheezing:AIDS-related bronchial leiomyomas. Pediatric Pulmonology,
24((2)), 106-10.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TC. (1997).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Laboratory Investigation,
76((3)), 439.
d'Amore, F. A., Stribley, JA., Ohno, T., Wu, G., Wickert, RS., Delabie, J., Hinrichs, SH. & Chan, W. C. (1997).
Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization.
Laboratory Investigation,
76((2)), 219-24.
d'Amore, F. A., Johansen, P., Houmand, A., Weisenburger, DD. & Mortensen, L. (1996).
Epstein-Barr virus genome in non-Hodgkin's lymphomas occuring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood,
87((3)), 1045-55.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TG. (1996).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Laboratory Investigation,
75((4)), 575-88.
Mandrup-Poulsen, T., Mølvig, J., Andersen, V., Bendtzen, K., Binder, C., Brøns, M.
, d'Amore, F. A., Dieperink, H., Erik, B., Frandsen, NE., Haase, H., Hey, H., Juul, J., Karstoft, E., Kemp, E., Laursen, HB., Mogensen, EF., Nerup, J., Pedersen, KE. ... Sagild, U. (1990).
Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study.
Ugeskrift for Laeger,
152(27), 1963-9.
Olsson, L., Behnke, O., Pleibel, N.
, d'Amore, F. A., Werdelin, O., Fry, KE. & Kaplan, HS. (1984).
Establishment and characterization of a giant cell line from a patient with Hodgkin's disease.
Journal of the National Cancer Institute,
73, 809-30.
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G. & Pannacciulli, I. (1984).
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexate. Tumori,
70, 223-26.
Sobrero, A., Muzzulini, C.
, d'Amore, F. A., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I. (1982).
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
Cancer Treatment Report,
66(12), 2061-70.